Siden han fjompen av en journalist ikke nevner trvx, så gjør jeg det:
“These types of multi-armed viruses are really promising and can directly deliver in the tumor multiple payloads such as immune modulators and boosters”
“We have indeed seen more investment in startups developing oncolytic viruses,”
Oncos 200 + alle samarbeidene de har
Another obstacle is that the immune system tries to destroy viruses before they can establish themselves, and many people already have immunity to some of the viruses used to develop treatments based on oncolytic viruses. This means that oncolytic viruses often need to be injected right into tumors to avoid contact with the immune system, which is technically harder than going through an intravenous route.
Oncos 102 systemic effect…